CNMD
Price
$47.71
Change
+$1.66 (+3.60%)
Updated
Oct 20, 11:05 AM (EDT)
Capitalization
1.38B
8 days until earnings call
Intraday BUY SELL Signals
LUCD
Price
$0.31
Change
-$0.07 (-18.42%)
Updated
Oct 20, 11:14 AM (EDT)
Capitalization
72.06M
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CNMD vs LUCD

CNMD vs LUCD Comparison Chart in %
View a ticker or compare two or three
VS
CNMD vs. LUCD commentary
Oct 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNMD is a Buy and LUCD is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CNMD with price predictions
Oct 19, 2026

CNMD's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for CNMD turned positive on October 15, 2026. Looking at past instances where CNMD's MACD turned positive, the stock continued to rise in 35 of 47 cases over the following month. The odds of a continued upward trend are 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CNMD's RSI Indicator exited the oversold zone, 24 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 57%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 67 cases where CNMD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.

Following a +2.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNMD advanced for three days, in 202 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CNMD as a result. In 72 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

CNMD moved below its 50-day moving average on September 17, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CNMD crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

The Aroon Indicator for CNMD entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. CNMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.324) is normal, around the industry mean (2.908). P/E Ratio (24.892) is within average values for comparable stocks, (2.616). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (11.052). Dividend Yield (0.017) settles around the average of (0.009) among similar stocks. P/S Ratio (1.055) is also within normal values, averaging (40.124).

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for LUCD with price predictions
Oct 19, 2026

LUCD sees MACD Histogram crosses below signal line

LUCD saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 30, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 46 instances where the indicator turned negative. In 40 of the 46 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LUCD as a result. In 81 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LUCD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

The Aroon Indicator for LUCD entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +8.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where LUCD advanced for three days, in 197 of 246 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

LUCD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. LUCD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.595) is normal, around the industry mean (2.908). P/E Ratio (-0.920) is within average values for comparable stocks, (2.616). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (21.645) is also within normal values, averaging (40.124).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LUCD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
CNMD: Fundamental Ratings
CNMD
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
81
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNMDLUCD
RSI
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
68%
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
82%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
81%
COMPARISON
Comparison
Oct 20, 2026
Stock price -- (CNMD: $46.05 vs. LUCD: $0.38)
Brand notoriety: CNMD and LUCD are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CNMD: 85% vs. LUCD: 298%
Market capitalization -- CNMD: $1.38B vs. LUCD: $72.06M
CNMD [@Medical/Nursing Services] is valued at $1.38B. LUCD’s [@Medical/Nursing Services] market capitalization is $72.06M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $180.06B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNMD’s FA Score shows that 1 FA rating(s) are green while LUCD’s FA Score has 1 green FA rating(s).

  • CNMD’s FA Score: 1 green, 4 red.
  • LUCD’s FA Score: 1 green, 4 red.
According to our system of comparison, both CNMD and LUCD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNMD’s TA Score shows that 4 TA indicator(s) are bullish while LUCD’s TA Score has 4 bullish TA indicator(s).

  • CNMD’s TA Score: 4 bullish, 5 bearish.
  • LUCD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LUCD is a better buy in the short-term than CNMD.

Price Growth

CNMD (@Medical/Nursing Services) experienced а +1.52% price change this week, while LUCD (@Medical/Nursing Services) price change was -36.83% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.67%. For the same industry, the average monthly price growth was -9.96%, and the average quarterly price growth was -11.00%.

Reported Earning Dates

CNMD is expected to report earnings on Oct 28, 2026.

LUCD is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Medical/Nursing Services (-3.67% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
CNMD
Daily Signal:
Gain/Loss:
LUCD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GCC26.820.07
+0.26%
WisdomTree Enhanced Commodity Strategy Fund (GCC)
QQUP60.10N/A
N/A
ProShares Ultra Top QQQ
ABXB18.68N/A
N/A
Abacus Flexible Bond Leaders ETF (ABXB)
PAB40.55-0.14
-0.33%
PGIM Active Aggregate Bond ETF (PAB)
EQTY29.32-0.11
-0.37%
Kovitz Core Equity ETF (EQTY)

CNMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNMD has been loosely correlated with NVST. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CNMD jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNMD
1D Price
Change %
CNMD100%
-1.43%
NVST - CNMD
49%
Loosely correlated
-1.27%
KIDS - CNMD
49%
Loosely correlated
+0.36%
IART - CNMD
48%
Loosely correlated
+1.82%
ENOV - CNMD
47%
Loosely correlated
+1.43%
ZBH - CNMD
46%
Loosely correlated
+0.01%
More

LUCD and

Correlation & Price change

A.I.dvisor tells us that LUCD and FEMY have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LUCD and FEMY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUCD
1D Price
Change %
LUCD100%
-21.05%
FEMY - LUCD
30%
Poorly correlated
-1.21%
BFLY - LUCD
28%
Poorly correlated
+3.03%
CNMD - LUCD
27%
Poorly correlated
-1.43%
CRL - LUCD
27%
Poorly correlated
-0.04%
ELMD - LUCD
26%
Poorly correlated
-0.07%
More